Article
Safeguarding VSMC Contractile Phenotype With In Situ circRNA-mediated Endothelial Olaratumab Engineering to Prevent Vascular Graft Stenosis.
Advanced materials (Deerfield Beach, Fla.) - 1 Mar 2026
Hu Shunqi, Ling Shifeng, Liang Fubang, Pan Yanjun, Wang Juan, Bao Wenjie, Zhu Jiameng, Wang Fan, Du Yawei, Cui Wenguo, Yin Meng
Abstract excerpt
Small-diameter vascular grafts (SDVGs) often fail due to restenosis driven by endothelial cell (EC)-derived PDGF-BB, which shifts vascular smooth muscle cells (VSMCs) toward a synthetic phenotype. Despite mechanistic insights, durable, localized, and cell-specific control of this crosstalk remains elusive. Here, we developed a circRNA-based in situ antibody engineering strategy to functionalize SDVGs,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
